论文部分内容阅读
目的探讨采取哮喘宁联合布地奈德气雾剂治疗支气管哮喘的临床效果。方法 84例支气管哮喘患者,随机分为观察组与对照组,每组42例。对照组给予单纯布地奈德气雾剂治疗,观察组给予哮喘宁联合布地奈德气雾剂治疗。对比两组患者的治疗效果。结果经治疗后,观察组患者中显效24例,有效16例,无效2例,总有效率为95.2%;对照组患者中显效17例,有效15例,无效10例,总有效率为76.2%;观察组总有效率高于对照组,差异有统计学意义(P<0.05)。观察组患者的肺活量为(2.27±0.32)L,对照组患者的肺活量为(1.85±0.14)L;观察组的肺活量改善情况明显优于对照组,差异有统计学意义(P<0.05)。结论在支气管哮喘治疗中,采取哮喘宁联合布地奈德气雾剂治疗后,取得了显著的治疗效果,值得在临床上大力推广。
Objective To investigate the clinical efficacy of asthma and budesonide aerosol in the treatment of bronchial asthma. Methods A total of 84 patients with bronchial asthma were randomly divided into observation group and control group, with 42 cases in each group. The control group was treated with simple budesonide aerosol, while the observation group was given asthma Ning combined budesonide aerosol. Compare the treatment effect of two groups of patients. Results After treatment, 24 cases were markedly effective in the observation group, 16 cases were effective, 2 cases were ineffective and the total effective rate was 95.2%. In the control group, 17 cases were markedly effective, 15 cases were effective and 10 cases were ineffective. The total effective rate was 76.2% ; The total effective rate in observation group was higher than that in control group, the difference was statistically significant (P <0.05). The vital capacity of the observation group was (2.27 ± 0.32) L, while that of the control group was (1.85 ± 0.14) L. The improvement of the vital capacity in the observation group was significantly better than that of the control group (P <0.05). Conclusion In the treatment of bronchial asthma, the combination of asthma and budesonide aerosol has achieved significant therapeutic effect, which is worth to be popularized clinically.